Asociación Colombiana de Medicina Interna,
Compared with placebo, once-daily LABA/LAMA (either IND/GLY, UMEC/VI or TIO/OLO) via a combination inhaler is associated with a…
Compared with placebo, once-daily LABA/LAMA (either IND/GLY, UMEC/VI or TIO/OLO) via a combination inhaler is associated with a…
Thanks to staff at the following places for doing the Cochrane Review! @SWBHnhs, Firestone Institute for Respiratory Health at @H…
Review included 22 RCTs involving 8641 people with COPD (9 crossovers). Participants received either once‐daily LABA/LAMA FDC (62…
New #CochraneEvidence: Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler…